TWI662032B - Method of producing thiamethoxam - Google Patents

Method of producing thiamethoxam Download PDF

Info

Publication number
TWI662032B
TWI662032B TW104116747A TW104116747A TWI662032B TW I662032 B TWI662032 B TW I662032B TW 104116747 A TW104116747 A TW 104116747A TW 104116747 A TW104116747 A TW 104116747A TW I662032 B TWI662032 B TW I662032B
Authority
TW
Taiwan
Prior art keywords
ammonium
chloride
item
patent application
methyl
Prior art date
Application number
TW104116747A
Other languages
Chinese (zh)
Other versions
TW201613913A (en
Inventor
詹姆斯 布里斯托
Original Assignee
香港商龍燈農業化工國際有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 香港商龍燈農業化工國際有限公司 filed Critical 香港商龍燈農業化工國際有限公司
Publication of TW201613913A publication Critical patent/TW201613913A/en
Application granted granted Critical
Publication of TWI662032B publication Critical patent/TWI662032B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

本文提供了一種製備噻蟲嗪的方法: 該方法包括將3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺: 與2-氯-5-氯甲基噻唑: This article provides a method for preparing thiamethoxam: This method includes 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine: With 2-chloro-5-chloromethylthiazole:

在包含二甲基甲醯胺(dimethylformamide,DMF)的溶劑系統、相轉移催化劑和鹼的存在下進行反應。 The reaction is performed in the presence of a solvent system containing dimethylformamide (DMF), a phase transfer catalyst, and a base.

Description

製備噻蟲嗪的方法 Method for preparing thiamethoxam

本發明涉及一種製備具有以下結構的3-(2-氯-1,3-噻唑-5-基甲基)-5-甲基-1,3,5-噁二嗪-4-亞基(硝基)胺(噻蟲嗪(thiamethoxam))的方法: The present invention relates to a method for preparing 3- (2-chloro-1,3-thiazol-5-ylmethyl) -5-methyl-1,3,5-oxadiazine-4- Method) (thiamethoxam):

Solovay在1978年報導了具有殺蟲活性的硝基亞甲基雜環化合物(“噻蟲嗪合成方法的研究”,Tao,Xian-jian;Huang,Chao-qun;Luo,Liang-ming,湖南化學工業研究所,中國長沙,現代農藥(2006),5(1),第11-13頁)。 Solovay reported a nitromethylene heterocyclic compound with insecticidal activity in 1978 ("Study on the Synthesis of Thiamethoxam", Tao, Xian-jian; Huang, Chao-qun; Luo, Liang-ming, Hunan Chemistry Industrial Research Institute, Changsha, China, Modern Pesticides (2006), 5 (1), pp. 11-13).

近年來,很多研究者通過研究官能團變化來關注硝基亞甲基雜環化合物的衍生物。在1980年代中期,拜爾公司(Bayer)成功地開發了商業規模的第一種新煙鹼類殺蟲劑,(E)-1-(6-氯-3-吡啶基甲基)-N-硝基亞咪唑烷-2-基胺(吡蟲啉(imidacloprid))。由於其新的作用模式、選擇性、效率和廣譜環境相容性的優良特徵,吡蟲啉在本領域引起了巨大關注,使得人們對新煙鹼類似物及其合成進行廣泛的研究。迄今為止,該研究和開發的結果使得超過12種產品被商業化,其中噻蟲嗪是最為突出的。 In recent years, many researchers have focused on derivatives of nitromethylene heterocyclic compounds by studying functional group changes. In the mid-1980s, Bayer successfully developed the first commercial-scale neonicotinoid insecticide, ( E ) -1- (6-chloro-3-pyridylmethyl) -N- Nitroimidazolidin-2-ylamine (imidacloprid). Because of its new mode of action, selectivity, efficiency, and broad-spectrum environmental compatibility, imidacloprid has attracted great attention in the field, leading to extensive research on neonicotinoids and their synthesis. As a result of this research and development, more than 12 products have been commercialized, of which thiamethoxam is the most prominent.

P.Maienfisch的“噻蟲嗪和相關化合物的合成和性質(Synthesis and Properties of Thiamethoxam and Related Compounds)”,Z.Naturforsch.61b,(2006),第353-359頁描述了噻蟲嗪開發和商業化。 P. Maienfisch, "Synthesis and Properties of Thiamethoxam and Related Compounds", Z. Naturforsch. 61b , (2006), pages 353-359 describe the development and commercialization of thiamethoxam Into.

噻蟲嗪是由硫雜煙鹼亞類開發的第一個商業化的新煙鹼類殺蟲劑,在1985年開始的對新煙鹼類物質進行研究的過程中被發現。對吡蟲啉的硝基亞胺基-雜環進行新的變化而發現4-硝基亞胺基-1,3,5-噁二嗪具有高殺蟲活性。在這些化合物中,確定噻蟲嗪是最佳化合物並選擇噻蟲嗪進行世界範圍內的研究。 Thiamethoxam is the first commercially available neonicotinoid insecticide developed from the thianicotine subclass. It was discovered during the study of neonicotinoids starting in 1985. New changes were made to the nitroimino-heterocycle of imidacloprid and 4-nitroimino-1,3,5-oxadiazine was found to have high insecticidal activity. Among these compounds, thiamethoxam was identified as the best compound and thiamethoxam was selected for worldwide research.

噻蟲嗪通過與煙鹼乙醯膽鹼受體結合進行作用。它表現出傑出的系統性特徵,並對大範圍的商業上非常重要的害蟲,例如,蚜蟲、葉蟬、粉虱、牧草蟲、稻飛蝨、科羅拉多土豆甲蟲、跳甲和切根蟲以及一些鱗翅類物種提供良好的控制。此外,證明噻蟲嗪具有對一些病毒轉移具有強的預防效果。噻蟲嗪被開發為同時用於葉/土壤應用,以及在全世界的大部分農作物中用作種子處理。低使用率、靈活的應用方法、良好的效率、長效殘餘活性和有利的安全分佈使得噻蟲嗪特別適合很多作物系統的現代化集成害蟲控制專案。 Thiamethoxam works by binding to the nicotine acetamidine receptor. It exhibits outstanding systemic characteristics and is important to a wide range of commercially important pests such as aphids, leafhoppers, whitefly, herbivores, rice planthoppers, Colorado potato beetle, beetle and root-cutting insects, and some Lepidopteran species provide good control. In addition, thiamethoxam has been shown to have a strong preventive effect on the transfer of some viruses. Thiamethoxam was developed for both leaf / soil applications and as seed treatment in most crops worldwide. Low utilization, flexible application methods, good efficiency, long-lasting residual activity and favorable safety distribution make thiamethoxam particularly suitable for modern integrated pest control projects in many crop systems.

合成噻蟲嗪有多種不同的路徑。最直截了當和普遍的方法是根據以下反應順序由3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑製備噻蟲嗪: There are many different pathways for the synthesis of thiamethoxam. The most straightforward and common method is to prepare thiacloprid from 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 2-chloro-5-chloromethylthiazole according to the following reaction sequence Azine:

但是,關鍵的中間體2-氯-5-氯甲基噻唑極不穩定,容易分解。因此,其穩定性對於噻蟲嗪的最終產率來說非常重要。2-氯-5-氯甲基噻唑還是一種強刺激物,其對噻蟲嗪的不完全轉化是非常不希望的。 However, the key intermediate, 2-chloro-5-chloromethylthiazole, is extremely unstable and easily decomposes. Therefore, its stability is very important for the final yield of thiamethoxam. 2-Chloro-5-chloromethylthiazole is also a strong irritant, and its incomplete conversion of thiamethoxam is highly undesirable.

WO 01/00623涉及一種製備硝基胍-和硝基烯胺衍生物的方法。公開了該方法適於形成噻蟲嗪,其中起始材料是3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑,如上所述。該方法包括將起始材料與相轉移催化劑和鹼反應。WO 01/00623列出了一長串用於 該方法的可能的溶劑,例如碳酸酯、特別是碳酸二甲酯、二甲基甲醯胺、乙腈、二甲基亞碸、丙酮,甲基乙基酮、乙酸乙酯。WO 01/00623特別示出在季銨鹽、碳酸鉀以及作為溶劑的碳酸二甲酯的存在下通過上述方法形成噻蟲嗪。報導的噻蟲嗪的最終產率僅為74%。該產率不適於以商業規模大量生產噻蟲嗪。 WO 01/00623 relates to a method for preparing nitroguanidine- and nitroenamine derivatives. The method is disclosed as being suitable for the formation of thiamethoxam in which the starting materials are 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 2-chloro-5-chloromethyl Thiazole, as described above. The method includes reacting a starting material with a phase transfer catalyst and a base. WO 01/00623 lists a long list for Possible solvents for this method are, for example, carbonates, in particular dimethyl carbonate, dimethylformamide, acetonitrile, dimethylsulfinium, acetone, methyl ethyl ketone, ethyl acetate. WO 01/00623 particularly shows the formation of thiamethoxam by the method described above in the presence of a quaternary ammonium salt, potassium carbonate and dimethyl carbonate as a solvent. The reported final yield of thiamethoxam was only 74%. This yield is not suitable for the large-scale production of thiamethoxam on a commercial scale.

如上所述,P.Maienfisch,“噻蟲嗪及其相關化合物的合成和性質”(Synthesis and Properties of Thiamethoxam and Related Compounds),Z.Naturforsch.61b,(2006),第353-359頁,公開了由3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑製備噻蟲嗪。該反應在碳酸鉀以及作為溶劑的二甲基甲醯胺(DMF)的存在下進行。所述噻蟲嗪的產率為71%。同樣,如此低的產率使該方法不適用於商業規模。 As mentioned above, P. Maienfisch, "Synthesis and Properties of Thiamethoxam and Related Compounds", Z. Naturforsch. 61b , (2006), pages 353-359, disclose Thiamethoxam was prepared from 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 2-chloro-5-chloromethylthiazole. This reaction is performed in the presence of potassium carbonate and dimethylformamide (DMF) as a solvent. The yield of the thiamethoxam was 71%. Also, such a low yield makes this method unsuitable for commercial scale.

因此,需要製備噻蟲嗪的改進的方法。如果改進的方法能使噻蟲嗪的產率增加則是有利的。此外,如果反應條件有利於2-氯-5-氯甲基噻唑的穩定性也是有利的。 Therefore, there is a need for an improved method for preparing thiamethoxam. It would be advantageous if the improved method could increase the yield of thiamethoxam. In addition, it is also advantageous if the reaction conditions are favorable for the stability of 2-chloro-5-chloromethylthiazole.

現已發現製備噻蟲嗪的改進的方法。具體地,發現在鹼、相轉移催化劑和包括二甲基甲醯胺(DMF)的溶劑系統的存在下,將3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和2-氯-5-氯甲基噻唑反應能以極高的產率製備噻蟲嗪。具體地,發現該方法以高產率製得噻蟲嗪,同時得到最少量的不希望的副產物。似乎上述反應條件有利於2-氯-5-氯甲基噻唑的穩定性,同時仍能使反應以高產率進行從而轉化為噻蟲嗪。 Improved methods of preparing thiamethoxam have now been discovered. Specifically, it was found that 3-methyl-N-nitro-1,3,5-oxadiazine-4 was present in the presence of a base, a phase transfer catalyst, and a solvent system including dimethylformamide (DMF). -The reaction of imine with 2-chloro-5-chloromethylthiazole can produce thiamethoxam in extremely high yields. In particular, this method was found to produce thiamethoxam in high yields while obtaining a minimal amount of undesirable by-products. It appears that the above reaction conditions are favorable for the stability of 2-chloro-5-chloromethylthiazole, while still allowing the reaction to proceed in high yields to convert to thiamethoxam.

相應地,本發明提供一種製備噻蟲嗪的方法: 該方法包括將3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺 與2-氯-5-氯甲基噻唑 Accordingly, the present invention provides a method for preparing thiamethoxam: The method includes converting 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine With 2-chloro-5-chloromethylthiazole

在包含二甲基甲醯胺(DMF)的溶劑系統、相轉移催化劑和鹼的存在下進行反應。 The reaction is performed in the presence of a solvent system containing dimethylformamide (DMF), a phase transfer catalyst, and a base.

令人驚訝地發現在相轉移催化劑和鹼的存在下與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺反應形成噻蟲嗪時,關鍵的中間體2-氯-5-氯甲基噻唑在包含DMF的溶劑系統中是高度穩定的。特別令人驚訝的是以極高的純度和極高的產率製得最終產物。具體地,本發明的方法能以高達98%的純度和超過90%的產率製備噻蟲嗪。這使得本發明的方法在以商業規模應用時特別有利。 It was surprisingly found that when reacting with 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine to form thiamethoxam in the presence of a phase transfer catalyst and a base, a key intermediate 2-Chloro-5-chloromethylthiazole is highly stable in solvent systems containing DMF. It is particularly surprising that the final product is produced with extremely high purity and very high yields. Specifically, the method of the present invention enables the preparation of thiamethoxam with a purity of up to 98% and a yield of more than 90%. This makes the method of the invention particularly advantageous when applied on a commercial scale.

本發明的方法採用包含二甲基甲醯胺(DMF)的溶劑系統。DMF可以與一種或多種其它溶劑,例如有機溶劑一起組合使用。更優選地,本發明方法所使用的溶劑系統基本上由DMF組成。 The method of the present invention uses a solvent system containing dimethylformamide (DMF). DMF can be used in combination with one or more other solvents, such as organic solvents. More preferably, the solvent system used in the method of the invention consists essentially of DMF.

所述方法還使用相轉移催化劑。合適的相轉移催化劑是本領域已知的。合適的相轉移催化劑的例子如WO 01/00623所述,包括聚合物相轉移催化劑、季銨鹽、季鏻鹽、冠醚、螯合劑、DABCO(1,4-二氮雜二環[2.2.2]辛烷)和DBU(1,5-二氮雜二環[4.3.0]壬-5-烯)及其季銨鹽。 The method also uses a phase transfer catalyst. Suitable phase transfer catalysts are known in the art. Examples of suitable phase transfer catalysts are described in WO 01/00623, including polymer phase transfer catalysts, quaternary ammonium salts, quaternary phosphonium salts, crown ethers, chelating agents, DABCO (1,4-diazabicyclo [2.2. 2] octane) and DBU (1,5-diazabicyclo [4.3.0] non-5-ene) and their quaternary ammonium salts.

優選地,所述相轉移催化劑是季銨鹽。瑞士布克斯市伏路卡公司(Fluka,Buchs,Switzerland)的論文“相轉移催化劑”,1986版,第7-25頁列出合適的季銨鹽。 Preferably, the phase transfer catalyst is a quaternary ammonium salt. A suitable quaternary ammonium salt is listed in the paper "Phase Transfer Catalyst" by Fluka, Buchs, Switzerland, 1986 edition, pages 7-25.

特別優選的季銨鹽是例如三甲基苄基氯化銨、三乙基苄基氯化銨、三丁基苄基氯化銨、三乙基苄基溴化銨、三甲基苄基甲醇銨、三甲基苄基氫氧化銨(triton B)、縮水甘油基三甲基氯化銨、十六烷基-三甲基氯化銨、十六烷基-三甲基溴化銨、十六烷基-溴化吡啶鎓、十六烷基-氯化吡啶鎓、2-羥乙基-三甲基氯化銨、2-羥乙基-三甲基氫氧化銨、苯基三甲基氯化銨、苯基三甲基氫氧化銨、四丁基氯化銨、四丁基溴化銨、四丁基氫氧化銨、四丁基四氟硼酸銨、四丁基硝酸銨、四癸基氯化銨、四(十二烷基)-乙酸銨、四乙基氯化銨、四乙基氫氧化銨、四(十二烷基)硝酸銨、四(十二烷基)甲苯磺酸銨、四己基氯化銨、四己基溴化銨、四甲基氯化銨、四甲基-溴化銨、四甲基氫氧化銨、四甲基碘化銨、四甲基甲苯磺酸銨、四辛基氯化銨、四丙基氯化銨、四丙基溴化銨、三丁基甲基氯化銨、三丁基庚基溴化銨,和氫氧化季銨,具體為五水合形式的四甲基氫氧化銨。優選的季銨鹽是三乙基苄基氯化銨(triethyl benzyl ammonium chloride,TEBA)。 Particularly preferred quaternary ammonium salts are, for example, trimethylbenzylammonium chloride, triethylbenzylammonium chloride, tributylbenzylammonium chloride, triethylbenzylammonium bromide, trimethylbenzylmethanol Ammonium, trimethyl benzyl ammonium hydroxide (triton B), glycidyl trimethyl ammonium chloride, cetyl-trimethyl ammonium chloride, cetyl-trimethyl ammonium bromide, ten Hexyl-pyridinium bromide, cetyl-pyridinium chloride, 2-hydroxyethyl-trimethylammonium chloride, 2-hydroxyethyl-trimethylammonium hydroxide, phenyltrimethyl Ammonium chloride, phenyltrimethylammonium hydroxide, tetrabutylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium hydroxide, tetrabutylammonium tetrafluoroborate, tetrabutylammonium nitrate, tetradecyl Ammonium chloride, tetra (dodecyl) -ammonium acetate, tetraethylammonium chloride, tetraethylammonium hydroxide, tetra (dodecyl) ammonium nitrate, tetra (dodecyl) toluenesulfonic acid Ammonium, tetrahexylammonium chloride, tetrahexylammonium bromide, tetramethylammonium chloride, tetramethyl-ammonium bromide, tetramethylammonium hydroxide, tetramethylammonium iodide, tetramethylammonium toluenesulfonate , Tetraoctyl ammonium chloride, tetrapropyl ammonium chloride, tetrapropyl ammonium bromide, tributyl Methylmethylammonium chloride, tributylheptylammonium bromide, and quaternary ammonium hydroxide, specifically tetramethylammonium hydroxide in a pentahydrate form. A preferred quaternary ammonium salt is triethyl benzyl ammonium chloride (TEBA).

本發明的方法也在鹼的存在下進行。合適的鹼是本領域已知的,並且市售可得。所述鹼優選是碳酸金屬鹽,更優選鹼金屬或鹼土金屬的碳酸鹽。優選地,所述鹼選自碳酸鈣、碳酸鈉、碳酸氫鈉、碳酸鉀、碳酸氫鉀及其混合物。碳酸鉀是用於本發明方法的特別優選的鹼。 The method of the present invention is also performed in the presence of a base. Suitable bases are known in the art and are commercially available. The base is preferably a metal carbonate, more preferably an alkali or alkaline earth metal carbonate. Preferably, the base is selected from the group consisting of calcium carbonate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, and mixtures thereof. Potassium carbonate is a particularly preferred base for use in the process of the invention.

在本發明的方法中,2-氯-5-氯甲基噻唑與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺反應。優選反應在升高的溫度下進行,具體地,在50-75℃、更優選55-70℃,更優選60-70℃的範圍進行。 In the method of the present invention, 2-chloro-5-chloromethylthiazole is reacted with 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine. The reaction is preferably carried out at an elevated temperature, specifically, in a range of 50-75 ° C, more preferably 55-70 ° C, and more preferably 60-70 ° C.

在該方法中,2-氯-5-氯甲基噻唑和3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺以1:1的化學計量比進行反應。但是,優選2-氯-5-氯甲基噻唑相對於3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺稍微過量,優選過量1-10%,更優選約為5%。 In this method, 2-chloro-5-chloromethylthiazole and 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine are reacted in a stoichiometric ratio of 1: 1. . However, it is preferred that 2-chloro-5-chloromethylthiazole is slightly excessive relative to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine, preferably an excess of 1-10%, more preferably It is preferably about 5%.

所述鹼在反應混合物中以任意合適的量存在。優選地,所述鹼與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺的重量比為1.1:1至2:1,更優選1.4:1至1.8:1,在很多實施方式中,比例為約1.7:1是合適的。 The base is present in the reaction mixture in any suitable amount. Preferably, the weight ratio of the base to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine is from 1.1: 1 to 2: 1, more preferably from 1.4: 1 to 1.8 : 1. In many embodiments, a ratio of about 1.7: 1 is suitable.

所述相轉移催化劑在反應混合物中以任意合適的量存在。優選地,所述相轉移催化劑與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺的重量比約為0.1:1至0.3:1,更優選約為0.2:1。 The phase transfer catalyst is present in the reaction mixture in any suitable amount. Preferably, the weight ratio of the phase transfer catalyst to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine is about 0.1: 1 to 0.3: 1, more preferably about 0.2: 1.

2-氯-5-氯甲基噻唑和3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺是本領域已知的化合物,都是市售可得的或者可以採用本領域已知的技術製備。 2-Chloro-5-chloromethylthiazole and 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine are compounds known in the art and both are commercially available Alternatively, it can be prepared using techniques known in the art.

在另一個方面中,本發明提供通過前述方法製備的噻蟲嗪。 In another aspect, the present invention provides thiamethoxam prepared by the aforementioned method.

本發明方法的實施方式通過以下具體實施例進行說明。 Embodiments of the method of the present invention are described by the following specific examples.

實施例Examples 實施例1 Example 1 3,6-二氫-3-甲基-N-硝基-2H-1,3,5-噁二嗪-4-胺的製備Preparation of 3,6-dihydro-3-methyl-N-nitro-2H-1,3,5-oxadiazine-4-amine

使用以下反應方案製備3,6-二氫-3-甲基-N-硝基-2H-1,3,5-噁二嗪-4-胺: The following reaction scheme was used to prepare 3,6-dihydro-3-methyl-N-nitro-2H-1,3,5-oxadiazine-4-amine:

將100kg N-甲基-硝基胍和64kg多聚甲醛裝入1000L反應器。加入350kg乙酸,之後將所得的混合物加熱至70℃,在該溫度下保持6小時。之後,在真空下蒸餾去除溶劑(乙酸)。在攪拌下加入175kg 10%的NaOH水溶液,之後將所得混合物冷卻並攪拌30分鐘。將所得混合物排入離心機進行分離。使用Biconical乾燥器乾燥得到的濾餅,得到98kg 3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺,為白色粉末(純度97%,產率71.5%)。 100 kg of N-methyl-nitroguanidine and 64 kg of paraformaldehyde were charged into a 1000 L reactor. After 350 kg of acetic acid was added, the resulting mixture was heated to 70 ° C and maintained at this temperature for 6 hours. After that, the solvent (acetic acid) was distilled off under vacuum. 175 kg of a 10% aqueous NaOH solution was added with stirring, after which the resulting mixture was cooled and stirred for 30 minutes. The resulting mixture was discharged into a centrifuge for separation. The obtained filter cake was dried using a Biconical dryer to obtain 98 kg of 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine as a white powder (97% purity, 71.5% yield) .

實施例2 Example 2 2-氯-5-氯甲基噻唑的製備Preparation of 2-chloro-5-chloromethylthiazole 2.1製備2-氯-烯丙基硫代異腈2.1 Preparation of 2-chloro-allyl thioisonitrile

使用以下反應方案製備2-氯-烯丙基硫代異腈: The following reaction scheme was used to prepare 2-chloro-allyl thioisocyanide:

在500L反應器中,將60.5kg 2,3-二氯丙烯與135kg甲苯、0.5kg TEBA(三乙基苄基氯化銨,作為催化劑)和44.1kg硫氰酸鈉混合。將得到的混合物在回流條件下(約100-105℃)加熱1.5小時,然後冷卻至室溫。加入50kg水,攪拌15分鐘,之後靜置混合物,發生相分層。在真空下從有機相中去除甲苯,使用Roots真空泵將殘留物在高真空下蒸餾。回收65kg蒸餾物2-氯-烯丙基硫代異腈,為黃色油狀液體(產率80%,純度90%)。 In a 500 L reactor, 60.5 kg of 2,3-dichloropropene were mixed with 135 kg of toluene, 0.5 kg of TEBA (triethylbenzyl ammonium chloride as a catalyst), and 44.1 kg of sodium thiocyanate. The resulting mixture was heated under reflux conditions (about 100-105 ° C) for 1.5 hours and then cooled to room temperature. 50 kg of water was added and stirred for 15 minutes, after which the mixture was allowed to stand and phase separation occurred. The toluene was removed from the organic phase under vacuum, and the residue was distilled under high vacuum using a Roots vacuum pump. 65 kg of 2-chloro-allyl thioisocyanide was recovered as a yellow oily liquid (yield 80%, purity 90%).

2.2 2-氯-5-(氯甲基)噻唑的製備2.2 Preparation of 2-chloro-5- (chloromethyl) thiazole

使用以下反應方案製備2-氯-5-(氯甲基)噻唑: The following reaction scheme was used to prepare 2-chloro-5- (chloromethyl) thiazole:

將65kg 2-氯-烯丙基硫代異腈與140kg四氯化碳在500L釉面反應器中混合。將35kg氯氣在1小時內鼓泡進入混合物,得到的混合物加熱至回流(77℃)3小時,然後冷卻至室溫。通過蒸餾去除四氯化碳。添加59kg二氯甲烷並攪拌,直至殘留物溶解,之後用86kg飽和NaHCO3溶液和40kg水洗滌溶液。得到的混合物用無水MgSO4乾燥,之後在真空下蒸餾去除二氯甲烷。最後,使用Roots真空泵在高 真空下蒸餾分離反應產物,得到61kg 2-氯-5-(氯甲基)噻唑,為黃色液體(產率84%,純度96%)。 65 kg of 2-chloro-allyl thioisocyanide and 140 kg of carbon tetrachloride were mixed in a 500 L glazed reactor. 35 kg of chlorine gas was bubbled into the mixture within 1 hour, and the resulting mixture was heated to reflux (77 ° C) for 3 hours and then cooled to room temperature. Carbon tetrachloride was removed by distillation. 59 kg of dichloromethane was added and stirred until the residue was dissolved, after which the solution was washed with 86 kg of saturated NaHCO 3 solution and 40 kg of water. The mixture obtained was dried over anhydrous MgSO 4, after the methylene chloride was removed under vacuum distillation. Finally, the reaction product was separated by distillation under high vacuum using a Roots vacuum pump to obtain 61 kg of 2-chloro-5- (chloromethyl) thiazole as a yellow liquid (yield 84%, purity 96%).

實施例3 Example 3 3.1噻蟲嗪的製備3.1 Preparation of thiamethoxam

通過以下反應方案製備噻蟲嗪: Thiamethoxam is prepared by the following reaction scheme:

47.5kg 3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺和50kg 2-氯-5-(氯甲基)噻唑進料至含350kg二甲基甲醯胺(DMF)的1000L釉面反應器中。得到的混合物進行加熱,將溫度保持在約65℃。之後,將82kg碳酸鉀和1kg三乙基苄基氯化銨(TEBA,作為催化劑)在20-40分鐘內加入反應器中。將得到的混合物反應4-5個小時,之後將混合物冷卻至室溫。將280kg水加入反應器中,攪拌混合物15分鐘,用32%的鹽酸將pH調節至6-7之間。將得到的混合物劇烈攪拌,加熱到65℃。使得到的混合物靜置30分鐘,之後排出水相,用二氯甲烷(DCM)(100kg×3)萃取3次。合併有機相,通過真空下蒸餾從混合物中去除DCM。使用Biconical乾燥器在40℃乾燥混合物,得到粗噻蟲嗪。 47.5 kg of 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine and 50 kg of 2-chloro-5- (chloromethyl) thiazole were fed to 350 kg of dimethylformamidine Amine (DMF) in a 1000 L glazed reactor. The resulting mixture was heated to maintain the temperature at about 65 ° C. Thereafter, 82 kg of potassium carbonate and 1 kg of triethylbenzyl ammonium chloride (TEBA, as a catalyst) were added to the reactor within 20-40 minutes. The resulting mixture was reacted for 4-5 hours, after which the mixture was cooled to room temperature. 280 kg of water was added to the reactor, the mixture was stirred for 15 minutes, and the pH was adjusted to 6-7 with 32% hydrochloric acid. The resulting mixture was stirred vigorously and heated to 65 ° C. The resulting mixture was allowed to stand for 30 minutes, and then the aqueous phase was discharged, and extracted three times with dichloromethane (DCM) (100 kg × 3). The organic phases were combined and the DCM was removed from the mixture by distillation under vacuum. The mixture was dried at 40 ° C using a Biconical dryer to obtain crude thiamethoxam.

3.2 噻蟲嗪的純化3.2 Purification of thiamethoxam

將20g粗製噻蟲嗪在100g甲醇中加熱,直至完全溶解。得到的溶液回流30-60分鐘,接著冷卻至室溫。對得到的混合物進行過濾以分離固體。得到的固體用甲醇洗滌數次,在高真空下乾燥,得到工業級純的噻蟲嗪晶體(產率90.5%,純度98%)。 20 g of crude thiamethoxam was heated in 100 g of methanol until completely dissolved. The resulting solution was refluxed for 30-60 minutes and then cooled to room temperature. The resulting mixture was filtered to separate solids. The obtained solid was washed several times with methanol and dried under high vacuum to obtain technical grade pure thiamethoxam crystals (yield 90.5%, purity 98%).

實施例4-9 Examples 4-9

在實施例4-9中重複實施例3,但是分別用碳酸二甲酯、四氯化碳、乙酸乙酯、1,2-二氯乙烯(DCE)、乙腈和甲基乙基酮作為溶劑代替DMF。實施例4-9中分別得到的噻蟲嗪的產率和純度資料與實施例3的比較示於以下表1。 Example 3 is repeated in Examples 4-9, but using dimethyl carbonate, carbon tetrachloride, ethyl acetate, 1,2-dichloroethylene (DCE), acetonitrile, and methyl ethyl ketone as solvents instead DMF. The yield and purity data of thiamethoxam obtained in each of Examples 4-9 and Table 3 are shown in Table 1 below.

從表1中可以看出,在反應方案中使用DMF作為溶劑與比較溶劑相比,DMF製備噻蟲嗪的產率明顯更高,純度明顯更高。 It can be seen from Table 1 that the use of DMF as a solvent in the reaction scheme compared with the comparison solvent, the yield of thiamethoxam by DMF is significantly higher, and the purity is significantly higher.

實施例10 Example 10

採用以下過程確定一系列不同溶劑中2-氯-5-(氯甲基)噻唑的穩定性:將20g 2-氯-5-(氯甲基)噻唑單獨溶解在100ml溶劑中,並攪拌2小時。使用的溶劑是DMF、碳酸二甲酯、四氯化碳、乙酸乙酯、1,2-二氯乙烯(DCE)、乙腈和甲基乙基酮。對於每種情況,隨後在真空下去除溶劑,收集乾燥的沉澱物。確定每種情況中2-氯-5-(氯甲基)噻唑和2-氯烯丙基異硫氰酸酯的量。結果列於下表2。較少量的2-氯烯丙基異硫氰酸酯表示2-氯-5-(氯甲基)噻唑具有更高的穩定性和較少的分解率。 The following procedure was used to determine the stability of 2-chloro-5- (chloromethyl) thiazole in a series of different solvents: 20 g of 2-chloro-5- (chloromethyl) thiazole was dissolved alone in 100 ml of solvent and stirred for 2 hours . The solvents used were DMF, dimethyl carbonate, carbon tetrachloride, ethyl acetate, 1,2-dichloroethylene (DCE), acetonitrile, and methyl ethyl ketone. In each case, the solvent was subsequently removed under vacuum and the dried precipitate was collected. The amount of 2-chloro-5- (chloromethyl) thiazole and 2-chloroallyl isothiocyanate was determined in each case. The results are shown in Table 2 below. A smaller amount of 2-chloroallyl isothiocyanate indicates that 2-chloro-5- (chloromethyl) thiazole has higher stability and less decomposition rate.

參照表2,可以看出在DMF中2-氯-5-氯甲基噻唑是高度穩定的,在DMF的存在下分解率小於6%。經比較,在其它溶劑中2-氯-5-氯甲基噻唑的分解率明顯更高。 Referring to Table 2, it can be seen that 2-chloro-5-chloromethylthiazole is highly stable in DMF, and the decomposition rate is less than 6% in the presence of DMF. By comparison, the decomposition rate of 2-chloro-5-chloromethylthiazole in other solvents is significantly higher.

Claims (13)

一種製備噻蟲嗪的方法:該方法包括將3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺:與2-氯-5-氯甲基噻唑:在二甲基甲醯胺(DMF)、相轉移催化劑和鹼的存在下進行反應。A method for preparing thiamethoxam: This method includes 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine: With 2-chloro-5-chloromethylthiazole: The reaction is performed in the presence of dimethylformamide (DMF), a phase transfer catalyst, and a base. 如申請專利範圍第1項所述的方法,其中該相轉移催化劑包括聚合物相轉移催化劑、季銨鹽、季鏻鹽、冠醚、螯合劑、DABCO(1,4-二氮雜二環[2.2.2]辛烷)和DBU(1,5-二氮雜二環[4.3.0]壬-5-烯)或其季銨鹽。The method according to item 1 of the scope of patent application, wherein the phase transfer catalyst comprises a polymer phase transfer catalyst, a quaternary ammonium salt, a quaternary phosphonium salt, a crown ether, a chelating agent, DABCO (1,4-diazabicyclo [ 2.2.2] octane) and DBU (1,5-diazabicyclo [4.3.0] non-5-ene) or their quaternary ammonium salts. 如申請專利範圍第2項所述的方法,其中該相轉移催化劑包括季銨鹽。The method according to item 2 of the patent application scope, wherein the phase transfer catalyst comprises a quaternary ammonium salt. 如申請專利範圍第3項所述的方法,其中該季銨鹽選自三甲基苄基氯化銨、三乙基苄基氯化銨、三丁基苄基氯化銨、三乙基苄基溴化銨、三甲基苄基甲醇銨、三甲基苄基氫氧化銨(triton B)、縮水甘油基三甲基氯化銨、十六烷基-三甲基氯化銨、十六烷基-三甲基溴化銨、十六烷基-溴化吡啶鎓、十六烷基-氯化吡啶鎓、2-羥乙基-三甲基氯化銨、2-羥乙基-三甲基氫氧化銨、苯基三甲基氯化銨、苯基三甲基氫氧化銨、四丁基氯化銨、四丁基溴化銨、四丁基氫氧化銨、四丁基四氟硼酸銨、四丁基硝酸銨、四癸基氯化銨、四(十二烷基)-乙酸銨、四乙基氯化銨、四乙基氫氧化銨、四(十二烷基)硝酸銨、四(十二烷基)甲苯磺酸銨、四己基氯化銨、四己基溴化銨、四甲基氯化銨、四甲基-溴化銨、四甲基氫氧化銨、四甲基碘化銨、四甲基甲苯磺酸銨、四辛基氯化銨、四丙基氯化銨、四丙基溴化銨、三丁基甲基氯化銨、三丁基庚基溴化銨,和氫氧化季銨。The method of claim 3, wherein the quaternary ammonium salt is selected from the group consisting of trimethylbenzyl ammonium chloride, triethylbenzyl ammonium chloride, tributylbenzyl ammonium chloride, and triethylbenzyl Ammonium bromide, trimethyl benzyl ammonium hydroxide, trimethyl benzyl ammonium hydroxide (triton B), glycidyl trimethyl ammonium chloride, cetyl-trimethyl ammonium chloride, cetyl Alkyl-trimethylammonium bromide, cetyl-pyridinium bromide, cetyl-pyridinium chloride, 2-hydroxyethyl-trimethylammonium chloride, 2-hydroxyethyl-trimethyl Methyl ammonium hydroxide, phenyltrimethylammonium chloride, phenyltrimethylammonium hydroxide, tetrabutylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium hydroxide, tetrabutyltetrafluoro Ammonium borate, tetrabutylammonium nitrate, tetradecylammonium chloride, tetra (dodecyl) -ammonium acetate, tetraethylammonium chloride, tetraethylammonium hydroxide, tetra (dodecyl) ammonium nitrate , Tetrakis (dodecyl) toluenesulfonate, Tetrahexylammonium chloride, Tetrahexylammonium bromide, Tetramethylammonium chloride, Tetramethyl-ammonium bromide, Tetramethylammonium hydroxide, Tetramethyl Ammonium iodide, tetramethyltoluenesulfonate, tetraoctylammonium chloride, tetrapropyl Ammonium, tetrapropyl ammonium bromide, methyl tributyl ammonium chloride, heptyl tributyl ammonium bromide, and quaternary ammonium hydroxides. 如申請專利範圍第4項所述的方法,其中該季銨鹽是三乙基苄基氯化銨(TEBA)。The method according to item 4 of the scope of patent application, wherein the quaternary ammonium salt is triethylbenzyl ammonium chloride (TEBA). 如前述申請專利範圍第1項所述的方法,其中該鹼是碳酸金屬鹽。The method according to item 1 of the aforementioned patent application scope, wherein the base is a metal carbonate. 如申請專利範圍第6項所述的方法,其中該鹼是鹼金屬碳酸鹽或鹼土金屬碳酸鹽,或其混合物。The method according to item 6 of the patent application scope, wherein the base is an alkali metal carbonate or an alkaline earth metal carbonate, or a mixture thereof. 如申請專利範圍第7項所述的方法,其中該鹼係選自碳酸鈣、碳酸鈉、碳酸氫鈉、碳酸鉀、碳酸氫鉀及其混合物。The method according to item 7 of the application, wherein the base is selected from the group consisting of calcium carbonate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, and mixtures thereof. 如申請專利範圍第8項所述的方法,其中該鹼是碳酸鉀。The method according to item 8 of the scope of patent application, wherein the base is potassium carbonate. 如前述申請專利範圍第1項所述的方法,其中該反應係在50-75℃的溫度範圍下進行。The method according to item 1 of the aforementioned patent application range, wherein the reaction is performed at a temperature range of 50-75 ° C. 如前述申請專利範圍第1項所述的方法,其中2-氯-5-氯甲基噻唑係相對於3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺以1至10%稍微過量存在於該反應混合物中。The method according to item 1 of the aforementioned patent application range, wherein 2-chloro-5-chloromethylthiazole is relative to 3-methyl-N-nitro-1,3,5-oxadiazine-4-yl The amine is present in the reaction mixture in a slight excess of 1 to 10%. 如前述申請專利範圍第1項所述的方法,其中該鹼與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺的重量比為1.1:1至2:1。The method according to item 1 of the aforementioned patent application range, wherein the weight ratio of the base to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine is 1.1: 1 to 2 :1. 如前述申請專利範圍第1項所述的方法,其中該相轉移催化劑與3-甲基-N-硝基-1,3,5-噁二嗪-4-亞胺的重量比為0.1:1至0.3:1。The method according to item 1 of the aforementioned patent application range, wherein the weight ratio of the phase transfer catalyst to 3-methyl-N-nitro-1,3,5-oxadiazine-4-imine is 0.1: 1 To 0.3: 1.
TW104116747A 2014-05-28 2015-05-26 Method of producing thiamethoxam TWI662032B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1409422.1A GB2511010B (en) 2014-05-28 2014-05-28 Method of producing thiamethoxam
??1409422.1 2014-05-28

Publications (2)

Publication Number Publication Date
TW201613913A TW201613913A (en) 2016-04-16
TWI662032B true TWI662032B (en) 2019-06-11

Family

ID=51177532

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104116747A TWI662032B (en) 2014-05-28 2015-05-26 Method of producing thiamethoxam

Country Status (5)

Country Link
CN (1) CN106029658B (en)
AR (1) AR100267A1 (en)
GB (1) GB2511010B (en)
TW (1) TWI662032B (en)
WO (1) WO2015180585A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262286A (en) * 2014-10-09 2015-01-07 山东科信生物化学有限公司 Synthetic method of thiamethoxam intermediate 3-methyl-4-nitroiminoperhydro-1,3,5-oxadiazine
CN107400123A (en) * 2017-08-28 2017-11-28 江苏绿叶农化有限公司 A kind of production method of Diacloden
CN107501256B (en) * 2017-09-21 2020-03-31 北京怡力生物科技有限公司 Preparation method of high-purity thiamethoxam
CN107698578A (en) * 2017-10-31 2018-02-16 江苏绿叶农化有限公司 A kind of preparation method of Diacloden
EP3480196A1 (en) * 2017-11-02 2019-05-08 Jiangsu Rotam Chemistry Co., Ltd Process for the preparation of thiamethoxam
CN108164522B (en) * 2018-02-13 2020-02-18 浙江永太科技股份有限公司 Synthetic method of thiamethoxam
CN110981866B (en) * 2019-12-17 2022-08-12 邯郸市瑞田农药有限公司 Thiamethoxam production method and extracting agent
CN113004218A (en) * 2020-12-10 2021-06-22 怀仁市普惠生物科技有限公司 Preparation method of dichloro pentachloromethyl thiazole
CN113121465A (en) * 2021-05-28 2021-07-16 安徽海顺化工有限公司 Synthesis process of 2-chloro-5-chloromethyl thiazole
CN115286624A (en) * 2022-08-04 2022-11-04 内蒙古犇星化学有限公司 Preparation method of thiamethoxam

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997010226A1 (en) * 1995-09-11 1997-03-20 Novartis Ag Process for preparing a 2-chloro-5-chloromethyl-thiazole compound
TWI254713B (en) * 1999-06-23 2006-05-11 Syngenta Participations Ag Method of producing nitroguanidine-and nitroenamine derivatives
CN102372702A (en) * 2011-11-17 2012-03-14 安徽省化工研究院 Preparation method for thiamethoxam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1401646A (en) * 2001-08-08 2003-03-12 南通江山农药化工股份有限公司 Insecticidal compound and production process thereof
GB2514927B (en) * 2014-05-28 2019-04-17 Rotam Agrochem Int Co Ltd Thiamethoxam and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997010226A1 (en) * 1995-09-11 1997-03-20 Novartis Ag Process for preparing a 2-chloro-5-chloromethyl-thiazole compound
TWI254713B (en) * 1999-06-23 2006-05-11 Syngenta Participations Ag Method of producing nitroguanidine-and nitroenamine derivatives
CN102372702A (en) * 2011-11-17 2012-03-14 安徽省化工研究院 Preparation method for thiamethoxam

Also Published As

Publication number Publication date
WO2015180585A9 (en) 2016-12-15
GB201409422D0 (en) 2014-07-09
CN106029658B (en) 2019-08-16
AR100267A1 (en) 2016-09-21
GB2511010A (en) 2014-08-20
TW201613913A (en) 2016-04-16
GB2511010B (en) 2017-05-03
WO2015180585A1 (en) 2015-12-03
CN106029658A (en) 2016-10-12

Similar Documents

Publication Publication Date Title
TWI662032B (en) Method of producing thiamethoxam
KR20100014384A (en) Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines
WO2018029641A1 (en) METHOD OF MANUFACTURING 4-CHLORO-7H-PYRROLO[2,3-d]PYRIMIDINE
JP3268461B2 (en) Method for producing nitroguanidine derivative
CN107043359A (en) A kind of preparation method of prothioconazoles intermediate
CN110878084A (en) Preparation method of nicosulfuron original drug
KR20120014005A (en) Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine
JP5266944B2 (en) Method for separating and purifying α-unsaturated amine compound
CZ20023395A3 (en) Novel preparation process of torsemide intermediate
US10053420B2 (en) Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine
WO1985000037A1 (en) 4-chloro-4-methyl-5-methylene-1,3-dioxolan-2-one
JP4231556B2 (en) Process for producing 1,3-disubstituted 2-nitroguanidine
JP5078211B2 (en) Method for producing heterocyclic compound
BR112016027652B1 (en) METHOD TO PRODUCE THIAMETOXAM
JP3098100B2 (en) Method for producing 2-chloro-5-aminomethylpyridines
EP2835371B1 (en) Industrial method for manufacturing high-purity methiozoline
JP4545152B2 (en) Process for producing N-substituted 3β-aminonortropane
CN109721529B (en) Simple preparation method of 2, 5-dichloropyridine
KR101348304B1 (en) Method of preparing of (2Z)-3-[(6-methylpyridin-3-yl)methyl-1,3-thiazolidin-2-ylidene]cyanamice
JP2659587B2 (en) 4-aziridinyl pyrimidine derivatives and their production
JP2653138B2 (en) Haloallylfuran carbinols and their preparation
JP2759809B2 (en) Process for producing E-isomer of imidazole derivative
EP0346881B1 (en) A process for producing furylpropargylcarbinol and a derivate thereof
TWI542578B (en) Preparation of Benzyl Nicotinic Acid Benzyl Ester Derivatives
JPS6248681A (en) Production of nitromethylene derivative

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees